Regenerative medicine, aquaculture, and other industries related to ATP-Bio are worth over $300B globally and are predicted to grow substantially by 2027.

Solid Organs / Tissues and Aquaculture markets are larger, more mature, with less growth. They are ripe for disruption from new technologies such as ATP-Bio. Regenerative medicine and cell therapies and MPS are emerging markets, with huge growth potential, and where ATP-Bio technologies can have a dramatic impact on that growth. ATP-Bio technologies are poised to improve all four of these markets, and thereby save more lives and feed more people.